摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-苄基-1-(3,5-二甲氧基苯基)甲亚胺 | 148171-51-1

中文名称
N-苄基-1-(3,5-二甲氧基苯基)甲亚胺
中文别名
——
英文名称
3,5-dimethoxybenzylidenebenzylamine
英文别名
(E)-N-Benzyl-1-(3,5-dimethoxyphenyl)methanimine;N-benzyl-1-(3,5-dimethoxyphenyl)methanimine
N-苄基-1-(3,5-二甲氧基苯基)甲亚胺化学式
CAS
148171-51-1
化学式
C16H17NO2
mdl
——
分子量
255.316
InChiKey
AWSKYUVSKHULDP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    403.6±45.0 °C(Predicted)
  • 密度:
    1.02±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    30.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Asymmetric aza-Diels-Alder reaction: enantio- and diastereoselective reaction of imine mediated by Chiral Lewis acid
    作者:Kouji Hattori、Hisashi Yamamoto
    DOI:10.1016/s0040-4020(01)80532-9
    日期:1993.2
    asymmetric aza-Diels-Alder reaction using chiral boron mediator is developed. The key to its success is the use of the chiral boron complex prepared in situ from (R)- or (S)- binaphthol and B(OPh)3. The enantiomeric reaction of prochiral imine affords products of up to 90% ee. The double asymmetric induction of chiral imine using α-benzylamine as a chiral auxiliary is achieved with almost complete diastereoselectivity
    开发了一种有效的使用手性介体的不对称aza-Diels-Alder反应。其成功的关键是使用由(R)-或(S)-联萘酚和B(OPh)3原位制备的手性配合物。前手性亚胺的对映体反应可提供高达90%ee的产物。使用α-苄基胺作为手性助剂,可以实现对脂肪族和芳香族亚胺几乎完全非对映选择性的手性亚胺的双不对称诱导。该方法适用于高效合成哌啶生物碱鸟嘌呤和芥酸。
  • An Air Stable Moisture Resistant Titanium Triflate Complex as a Lewis Acid Catalyst for CC Bond Forming Reactions
    作者:Steven D. Bull、Matthew G. Davidson、Andrew L. Johnson、Mary F. Mahon、Diane E. J. E. Robinson
    DOI:10.1002/asia.200900305
    日期:2010.3.1
    An air and moisture stable C3‐symmetric titanium(IV) triflate, supported by a tripodal amine‐(tris‐phenolate) ligand, has been synthesized and characterized by X‐ray crystallography and shown to be a good Lewis acid catalyst for a range of aza‐Diels–Alder, Diels–Alder, syn aldol, allylation, and alkylation reactions.
    由X射线晶体学合成并表征了一种空气和湿气稳定的C 3对称的三氟甲磺酸三氟甲磺酸(IV),并通过X射线晶体学对其进行了表征,显示出在一定范围内是很好的路易斯酸催化剂的氮杂-Diels-桤木,狄尔斯-阿德耳,顺式羟醛,烯丙基化,和烷基化反应。
  • From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells
    作者:Roberta Listro、Alessio Malacrida、Francesca Alessandra Ambrosio、Giacomo Rossino、Marcello Di Giacomo、Valeria Cavalloro、Martina Garbagnoli、Pasquale Linciano、Daniela Rossi、Guido Cavaletti、Giosuè Costa、Stefano Alcaro、Mariarosaria Miloso、Simona Collina
    DOI:10.3390/ijms232113061
    日期:——

    The insurgence of drug resistance in treating Multiple Myeloma (MM) still represents a major hamper in finding effective treatments, although over the past decades new classes of drugs, such as proteasome inhibitors and immunomodulatory drugs, have been discovered. Recently, our research team, within a Nature-Aided Drug Discovery project, isolated from Hibiscus Sabdariffa L. calyces the secondary metabolite called Hib-ester which possesses antiproliferative properties against human multiple myeloma RPMI 8226 cells, reduces migration and cell invasion and inhibits proteasome without neurotoxic effects. In the present study, we explored the chemical spaces of the hit compound Hib-ester. We explored the structure-activity relationships (SAR), and we optimized the scaffold through sequentially modifying Hib-ester subunits. Compound screening was performed based on cytotoxicity against the RPMI 8226 cells to assess the potential efficacy toward human MM. The ability of the most effective molecules to inhibit the proteasome was evaluated and the binding mode of the most promising compounds in the proteasome chymotrypsin binding pocket was deciphered through molecular modeling simulations. Compounds 13 and 14 are more potent than Hib-ester, demonstrating that our strategy was suitable for the identification of a novel chemotype for developing possible drug candidates and hopefully widening the drug armamentarium against MM.

    过去几十年来,虽然蛋白酶抑制剂免疫调节药物等新药不断被发现,但治疗多发性骨髓瘤(MM)的抗药性问题仍然是找到有效治疗方法的主要障碍。最近,我们的研究团队在一个自然辅助药物发现项目中,从木槿萼片中分离出了一种名为 Hib-ester 的次级代谢产物,它具有抗人多发性骨髓瘤 RPMI 8226 细胞增殖的特性,能减少细胞迁移和侵袭,并能抑制蛋白酶体,且无神经毒性作用。在本研究中,我们探索了命中化合物 Hib-ester 的化学空间。我们探索了结构-活性关系(SAR),并通过连续修饰 Hib-ester 亚基优化了支架。根据对 RPMI 8226 细胞的细胞毒性进行了化合物筛选,以评估对人类 MM 的潜在疗效。评估了最有效分子抑制蛋白酶体的能力,并通过分子建模模拟破译了最有希望的化合物在蛋白酶体糜蛋白酶结合袋中的结合模式。化合物 13 和 14 比 Hib-ester 更有效,这表明我们的策略适用于鉴定新的化学类型,以开发可能的候选药物,并有望扩大抗 MM 的药物范围。
  • Steric and electronic effects on the regioselective formation of platinum(II) metallacycles: crystal structure of [PtMe(3-MeC6H3CHNCH2C6H5)(PPh3)]
    作者:Margarita Crespo、Xavier Solans、Mercè Font-Bardía
    DOI:10.1016/0022-328x(96)83109-3
    日期:1996.2
    The reaction of [Pt(2)Me(4)(mu-SMe(2))(2)] (1) with imines 3,4-(OMe)(2)C6H3CH=NCH(2)Ph (2c) and 3-MeC(6)H(6)CH=NCH(2)Ph (2e) yields cyclometallated compounds [PtMe(3,4-(OMe)(2)C6H2CH=NCH(2)Ph)(SMe(2))] (4c) and [PtMe(3-MeC(6)H(3)CH=NCH(2)Ph)(SMe(2))] (4e) arising from selective metallation at the less hindered of the two non-equivalent ortho positions of the aryl ring, followed by loss of methane. These compounds react with PPh(3) to give cyclometallated compounds [PtMe(3,4-(OMe)(2)C6H2CH=NCH(2)Ph)(PPh(3))] (5c) and [PtMe(3-MeC(6)H(3)CH=NC(2)Ph)(PPh(3))] (5e). Imines 2,4,6-(OMe)(3)C6H2CH=NCH(2)Ph (2a), 3,5-(OMe)(2)C6H3CH=NCH(2)Ph (2b) and 2,5-Me(2)C(6)H(3)CH=NCH(2)Ph (2d) coordinate to platinum through the nitrogen atom to yield compounds [PtMe(2)(ArCH=NCH(2)Ph)(SMe(2))] (3) but fail to produce cyclometallated compounds.
  • Cyclometallation of 3,5 disubstituted N-benzylideneamines by palladium(II). Synthesis and X-ray crystal structure of [Pd(3,5-F2C6H2CHNC6H5)Br(PPh3)2]
    作者:Joan Albert、Jaume Granell、Rosa Moragas、Joaquim Sales、Mercè Font-Bardía、Xavier Solans
    DOI:10.1016/0022-328x(94)05365-i
    日期:1995.5
    The action of Pd(AcO)(2) on the imines C6R(5 . m)CH=N(CH2)(n)C6H5 have been studied. Five-membered endo metallacyles were obtained from the imines 1a (R=3,5-F-2, n=0), 1b (R=3,5-F-2, n=1), 1c (R=3,5-(MeO)(2), n=0) and 1d (R=3,5-(MeO)(2), n=1), by activation of a O(aromatic)-H bond, in spite of the presence of MeO or F substituents on the carbon atom adjacent to the metallation H-1 NMR spectra of the acetate bridged compounds [Pd(C-N)(mu-AcO)}(2)] (2a-d) obtained show the existence of different isomers in solution. Complexes [PdBr(C-N)(PPh(3))] (4) and [PdBr(C-N)(PPh(3))(2)] (5) can be obtained by the action of PPh(3) on the new cyclometallated compounds. [Pd(3,5-F2C6H2CH=NC6H5)Br(PPh(3))(2)] crystallizes in the space group P2(1)/a with a=20.224(4), b=17.447(3), c=12.290(2) Angstrom, beta=110.12(3)degrees and Z=4. The dihedral angle between the metallated phenyl ring and the coordination plane is 86.6 degrees. An N=CH proton and a fluorine atom ortho to the Pd-C bond occupy the apical positions in the coordination sphere of the palladium atom.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫